Results 241 to 250 of about 769,860 (308)

A Cross-Sectional Study on the Role of Biochemical Markers in Cardiovascular Disease Risk Assessment: Comparison of Urban and Rural Populations in Pakistan. [PDF]

Health Sci Rep
Kumar M, Davi S, Kumar A, Hanif ZM, Ghansham FNU, Bai C, Kumar S, Kumar J, Kumar M, Zaheer M, Venjhraj FNU, Verma A.   +11 more
europepmc   +1 more source

Denosumab Offers Relatively Lower Initial Protection Against Osteoporotic Vertebral Fractures in Treatment‐Naive Patients Compared With Zoledronate

Clinical Pharmacology &Therapeutics, EarlyView.
We compared the initial efficacy of denosumab (Dmab) and zoledronate (ZOL) in treatment‐naive patients with osteoporosis. This cohort study, based on TriNetX data, evaluated the risks of fractures and mortality using Kaplan–Meier survival analyses, with hazard ratios (HRs) and 95% confidence intervals (CIs).
Ko‐Hsiu Lu, Shiow‐Ing Wang, Shun‐Fa Yang   +2 more
wiley   +1 more source

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

A missing link for efflux pumps. [PDF]

Elife
Wehbi H, Broutin I.
europepmc   +1 more source

Friedewald and Martin-Hopkins formulae for estimating low-density lipoprotein cholesterol in a Malagasy population. [PDF]

Afr J Lab Med
Rakotonjafiniarivo FH, Antsonantenaina T, Rakotomalala MS, Andriambelo RD, Ranaivosoa MK.   +4 more
europepmc   +1 more source

The First Case of Lipoprotein Glomerulopathy in a Patient With Male Infertility. [PDF]

Kidney Med
Ye C, Wang Y, Liang C, Wang Y, Zhang C, Jiang H.   +5 more
europepmc   +1 more source

Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update. [PDF]

J Clin Med
Domański I, Kozieł A, Domański J, Trocha M.   +3 more
europepmc   +1 more source

Disease-specific crosstalk of Alistipes with lipoprotein profiles in overweight individuals at high cardiometabolic risk. [PDF]

Sci Rep
Cuevas-Sierra A, Higuera-Gómez A, de Cuevillas B, Amigó N, Martínez-Urbistondo M, Castejón R, Vargas JA, Martínez JA.   +7 more
europepmc   +1 more source

Association between non-traditional lipid-inflammatory parameters and incident diabetes: a national prospective cohort study. [PDF]

BMC Endocr Disord
Hua J, Jiang Q, Cao S, Wang F.
europepmc   +1 more source

Real-World Effectiveness of Bempedoic Acid in Reducing LDL-C: An Electronic Medical Records-Based Analysis. [PDF]

JACC Adv
Katzmann JL, Becker C, Schneider TF, Articus K, Keuken G, Laufs U.   +5 more
europepmc   +1 more source